AstraZeneca said today that it has taken up late-stage study by enrolling 30,000 subjects in order to come up with the COVID-19 vaccine. Watch: "I am pleased to announce that AstraZeneca's vaccine has reached Phase 3 clinical trials and has joined various vaccines that are close to the end.

AstraZeneca's vaccine has reached Phase 3 clinical trials: Trump

Scientists in the United States have developed a coronavirus vaccine which can be given in one dose and is effective in preventing infection in mice susceptible to COVID-19, a study revealed.

Nasal vaccine prevents coronavirus in mice: Study

All you want to know about Russia's coronavirus vaccine 'Sputnik V'

After Russian President Putin announced the "first" coronavirus vaccine was ready to be launched in the country, the health ministry said that it planned to produce 5 million doses by December-January.

Amid scepticism, Russia says will produce 5 million vaccine doses by December-January

Health and Human Services Secretary of the United States Alex Azar on Wednesday reacted to the announcement from Russia that it has approved a ‘world first’ Covid-19 vaccine.

Point is to have a safe vaccine, not the first one: US on Russia’s coronavirus vaccine

After President Putin announced that Russia had launched the world's first coronavirus vaccine, Germany's health ministry said that "there is no known data on the quality, efficacy and safety of the Russian vaccine.

No known data on quality, safety of Russian vaccine: German health ministry

After President Vladimir Putin declared that the country had developed the world's first coronavirus vaccine, the World Health Organization(WHO) said it was "discussing the new COVID-19 vaccine with Russia.

In contact with Russia over vaccine, rigorous review and assessment required: WHO

Indian Council of Medical Research(ICMR) said today that Oxford vaccine being manufactured by Serum Institute of India has got approval for phase 2 and 3 clinical trials.

Oxford vaccine clinical trials in India to take place in 17 sites: ICMR

The US government will pump in $2.1 billion in two pharma companies Sanofi and GlaxoSmithKline(GSK) to combat the coronavirus pandemic as part of Operation Warp Speed.

Trump administration to pump $2.1 billion for Sanofi, GSK coronavirus vaccine

The press is giving the people a shot by shot account of coronavirus vaccine research and whoever makes the vaccine may end up making a world record because usually it takes years to develop a vaccine.

As COVID-19 engulfs the world, vaccine trials move into top gear

It is a race against time to hunt for coronavirus vaccine because a vaccine appears to be the only exit strategy from the pandemic with research taking place at breakneck speed.

All you want to know about the coronavirus vaccine race